Medical comms - Press Releases

Date	Title	Company
30-Sep-2020	200 Reasons to Celebrate - Fusion Antibodies successfully completes their 200th antibody humanisation	Fusion Antibodies
30-Sep-2020	Digital Science's Dimensions has partnered with Google Cloud, launches integration with BigQuery	Dimensions from Digital Science
28-Sep-2020	VAL201 Clinical Trial Update	ValiRx
28-Sep-2020	Sosei Heptares announces that a second novel drug candidate from its multi-target drug discovery collaboration with Pfizer has started clinical trials	Sosei Heptares
28-Sep-2020	Sanofi completes Principia Biopharma Inc. acquisition	Sanofi
28-Sep-2020	Aqilion and Immunscape discontinue their joint feasibility study in oncology	AQILION AB
28-Sep-2020	Inceptua receives approval of marketing authorization transfer of Jetrea® (ocriplasmin) for the treatment of symptomatic vitreomacular adhesion	Inceptua Group
28-Sep-2020	Two-Year Data of Evrysdi™ (risdiplam) in Infants with Spinal Muscular Atrophy Demonstrate Continued Improvement of Developmental Milestones	PTC Therapeutics, Inc.
25-Sep-2020	PharmiWeb.Jobs welcomes Medella Life	Medella Life
24-Sep-2020	Survey highlights physical and mental burden of anaemia of chronic kidney disease, with 41% of patients expressing feelings of social isolation	Astellas Pharma Europe Ltd
24-Sep-2020	Zuhlke supported the development and launch of the new NHS Covid-19 app for England & Wales	Zuhlke
24-Sep-2020	ICR and Cancer Research UK spinout company Monte Rosa Therapeutics raises $96m in ‘Series B’ Financing	ICR and Cancer Research UK
24-Sep-2020	Algenex inaugurates new facility with capacity to produce up to 100 million vaccine doses	Algenex SL
24-Sep-2020	Vifor Pharma announces outcome of AFFIRM-AHF topline data	Vifor Pharma
24-Sep-2020	GLEAMER raises € 7.5 million to market A.I. platform offering radiologists semi-automated diagnosis of medical images	GLEAMER
24-Sep-2020	MMS and Pharmacy Automation is Easing the Pressure During COVID-19	Becton, Dickinson and Company
23-Sep-2020	Salvia BioElectronics raises EUR 26M (USD 31M) to develop innovative neurostimulation therapy for chronic migraine	Salvia BioElectronics
23-Sep-2020	Aqilion announces identity of drug target and presents novel data from the drug discovery program Alnitak	Aqilion
23-Sep-2020	Interim results for the six months ended 30 June 2020 Strong performance from Consumer Healthcare brands; cash generation remains robust; full year results tracking in line with market expectations	ALLIANCE PHARMA PLC
23-Sep-2020	Nemaura Medical Licenses Validated Mobile Application to Create Powerful Diabetes Prevention and Management Suite of Products	Nemaura Medical, Inc.